glp 1 course GLP-1 meds are shaking up the fitness and wellbeing space, and coaches who understand them are already ahead of the curve. Our Navigating GLP-1 for Sport and Physical Activity Professionals gives GLP-1 RA Microdosing: A
Description
Non-diabetic patients face different risks than diabetic patients
Clinically, a majority of T2DM cases are due to obesity
Furthermore, we demonstrated in animal studies that GLP-1 secretion induced by these factors does not evoke aversive behaviors, unlike GLP-1RAs, and promotes satiation, thereby suppressing hyperphagia and weight gain induced by a high-fat diet
What deserves careful thought before starting: compounded medications are not FDA-approved, the regulatory environment for compounded GLP-1s is actively shifting as of mid-2026 with a live FDA comment period closing June 29, consultation fees are non-refundable once incurred, and prescription approval is not guaranteed
We believe in providing helpful information to our community, which is why we want patients to understand emerging options like the GLP-1 patch
People with severe chronic nausea or vomiting from other causes
